Tesamorelin has an FDA-approved HIV lipodystrophy indication, but not for longevity, ordinary weight loss, cognition, bodybuilding, or anti-aging.
Retatrutide is promising in obesity trials, but products sold as retatrutide outside trials have triggered liver-toxicity warnings. Here is how clinic buyers can separate legitimate care from grey-market peptide risk.
A buyer-protection guide to follistatin gene therapy longevity clinic claims, covering evidence limits, FDA and EMA regulation, red flags, and questions before paying.
Peptide therapy is the fastest-growing treatment category at longevity clinics. But RFK Jr.'s push to reclassify 12 banned peptides has created confusion. Here's which peptides clinics actually use, what the evidence says, what they cost, and how to choose a clinic.
HHS Secretary Kennedy announced ~14 peptides will move from Category 2 (restricted) to Category 1 (legal for compounding). Here's what the reclassification means for longevity medicine, which peptides are returning, and why physician oversight matters more than ever.